Great West Life Assurance CO Bio Rad Laboratories, Inc. Transaction History

Great West Life Assurance CO

  • $53.1 Billion
  • Q2 2024

A detailed history of Great West Life Assurance CO transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 9,829 shares of BIO stock, worth $3.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,829
Previous 7,670 28.15%
Holding current value
$3.28 Million
Previous $2.65 Million 1.13%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$268.26 - $339.48 $579,173 - $732,937
2,159 Added 28.15%
9,829 $2.68 Million
Q1 2024

May 13, 2024
SELL
$304.11 - $351.99 $260,926 - $302,007
-858 Reduced 10.06%
7,670 $2.65 Million
Q4 2023

Feb 13, 2024
BUY
$269.37 - $365.04 $107,748 - $146,016
400 Added 4.92%
8,528 $2.74 Million
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $31,872 - $38,459
-91 Reduced 1.11%
8,128 $2.92 Million
Q2 2023

Aug 10, 2023
SELL
$359.49 - $486.4 $202,392 - $273,843
-563 Reduced 6.41%
8,219 $3.13 Million
Q1 2023

May 12, 2023
SELL
$418.69 - $503.0 $2.58 Million - $3.1 Million
-6,172 Reduced 41.27%
8,782 $4.21 Million
Q4 2022

Feb 10, 2023
SELL
$351.71 - $456.01 $2.56 Million - $3.32 Million
-7,283 Reduced 32.75%
14,954 $6.31 Million
Q3 2022

Nov 01, 2022
BUY
$412.59 - $563.26 $9.17 Million - $12.5 Million
22,237 New
22,237 $9.27 Million
Q2 2022

Aug 09, 2022
SELL
$463.67 - $597.16 $768,301 - $989,494
-1,657 Reduced 6.49%
23,891 $11.8 Million
Q1 2022

May 12, 2022
SELL
$524.57 - $735.42 $1.1 Million - $1.54 Million
-2,099 Reduced 7.59%
25,548 $15.1 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $195,639 - $219,331
-276 Reduced 0.99%
27,647 $20.8 Million
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $1.19 Million - $1.49 Million
-1,807 Reduced 6.08%
27,923 $21 Million
Q2 2021

Aug 11, 2021
BUY
$576.64 - $649.04 $2.14 Million - $2.41 Million
3,709 Added 14.25%
29,730 $19.1 Million
Q1 2021

May 17, 2021
BUY
$547.01 - $662.35 $874,121 - $1.06 Million
1,598 Added 6.54%
26,021 $14.8 Million
Q4 2020

Feb 16, 2021
BUY
$510.68 - $643.45 $641,414 - $808,173
1,256 Added 5.42%
24,423 $14.2 Million
Q3 2020

Nov 17, 2020
SELL
$454.43 - $535.6 $3.78 Billion - $4.45 Billion
-8,315,086 Reduced 99.72%
23,167 $11.9 Million
Q3 2020

Nov 13, 2020
BUY
$454.43 - $535.6 $3.78 Billion - $4.46 Billion
8,319,815 Added 45123.2%
8,338,253 $4.3 Billion
Q2 2020

Aug 17, 2020
SELL
$334.87 - $493.06 $2.46 Million - $3.62 Million
-7,346 Reduced 28.49%
18,438 $8.3 Million
Q1 2020

May 14, 2020
BUY
$320.01 - $409.07 $904,028 - $1.16 Million
2,825 Added 12.3%
25,784 $9.08 Million
Q4 2019

Feb 11, 2020
BUY
$319.73 - $374.2 $3.2 Million - $3.74 Million
10,008 Added 77.28%
22,959 $8.5 Million
Q3 2019

Oct 25, 2019
BUY
$304.55 - $345.24 $289,931 - $328,668
952 Added 7.93%
12,951 $4.31 Million
Q2 2019

Jul 31, 2019
BUY
$286.93 - $312.59 $3.44 Million - $3.75 Million
11,999 New
11,999 $0
Q1 2019

May 08, 2019
SELL
$224.3 - $317.41 $2.79 Million - $3.95 Million
-12,450 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$220.1 - $309.0 $192,807 - $270,684
876 Added 7.57%
12,450 $2.68 Million
Q2 2018

Aug 10, 2018
SELL
$244.1 - $303.88 $76,159 - $94,810
-312 Reduced 2.62%
11,574 $3.34 Million
Q1 2018

May 10, 2018
BUY
$233.97 - $274.11 $70,191 - $82,233
300 Added 2.59%
11,886 $2.97 Million
Q4 2017

Feb 09, 2018
SELL
$216.94 - $271.3 $75,929 - $94,955
-350 Reduced 2.93%
11,586 $2.76 Million
Q3 2017

Nov 09, 2017
BUY
$212.27 - $242.28 $2.53 Million - $2.89 Million
11,936
11,936 $2.65 Million

Others Institutions Holding BIO

# of Institutions
460
Shares Held
19.6M
Call Options Held
23.2K
Put Options Held
37.4K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.22B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email